Home Combat Arthritis Kevzara Fails COVID-19 Patients for the Last Time

Kevzara Fails COVID-19 Patients for the Last Time

Sep 04, 2020 comments off

Kevzara Fails COVID-19 Patients for the Last Time

Sanofi and Regeneron reported a phase 3 failure with their rheumatoid arthritis treatment and severely affected COVID-19 patients.

Read More…

You May Also Like

COVID-19 roundup: Flu may be linked with coronavirus spread, RA drug could aid recovery | Daily Sabah – Daily Sabah

Initial data from a pair of clinical trials may revive interest in arthritis drugs as COVID-19 treatments

Roche says its drugs reduce ventilator need for COVID-19 patients – Reuters UK

Flu outbreaks may be linked to COVID-19; arthritis drug benefit seen – Reuters India

Flu outbreaks may be linked to COVID-19; arthritis drug benefit seen – Reuters UK

Eli Lilly's drug cuts COVID-19 recovery time in remdesivir-combo study – Reuters India